Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.

Jairam V, Park HS, Decker RH.

Cancer J. 2020 Mar/Apr;26(2):129-136. doi: 10.1097/PPO.0000000000000433.

PMID:
32205537
2.

Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.

Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB 2nd, Bradley JD, Aisner J, Malhotra J.

JAMA Oncol. 2020 Feb 20. doi: 10.1001/jamaoncol.2019.6731. [Epub ahead of print]

PMID:
32077891
3.

Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer.

Saeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS.

Head Neck. 2020 Feb 3. doi: 10.1002/hed.26086. [Epub ahead of print]

PMID:
32011055
4.

Contemporary Topics in Radiation Medicine: Skin Cancer.

Gao SJ, Decker RH.

Hematol Oncol Clin North Am. 2020 Feb;34(1):189-203. doi: 10.1016/j.hoc.2019.09.008. Review.

PMID:
31739944
5.

A new approach to predicting risk for N2 disease in non-small cell lung cancer.

Decker RH, Blasberg JD.

J Thorac Dis. 2019 Sep;11(Suppl 15):S1973-S1975. doi: 10.21037/jtd.2019.07.61. No abstract available.

6.

SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.

Young MR, Decker RH.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):121-123. doi: 10.1016/j.ijrobp.2019.05.021. No abstract available.

PMID:
31422805
7.

Novel Eye Plaque Designs for Brachytherapy of Iris and Ciliary Body Melanoma and the First Clinical Application.

Liu W, Kim JM, Young BK, Nath R, Chen Z, Decker RH, Astrahan MA, Pointdujour-Lim R.

Ocul Oncol Pathol. 2019 Apr;5(3):220-227. doi: 10.1159/000493269. Epub 2018 Oct 11.

8.

Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.

Kann BH, Verma V, Stahl JM, Ross R, Dosoretz AP, Shafman TD, Gross CP, Park HS, Yu JB, Decker RH.

Radiother Oncol. 2019 May;134:44-49. doi: 10.1016/j.radonc.2019.01.027. Epub 2019 Feb 1.

PMID:
31005223
9.

Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.

Kann BH, Miccio JA, Stahl JM, Ross R, Verma V, Dosoretz AP, Park HS, Shafman TD, Gross CP, Yu JB, Decker RH.

Radiother Oncol. 2019 Mar;132:188-196. doi: 10.1016/j.radonc.2018.10.017. Epub 2018 Oct 31.

PMID:
30391106
10.

Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks.

Kann BH, Aneja S, Loganadane GV, Kelly JR, Smith SM, Decker RH, Yu JB, Park HS, Yarbrough WG, Malhotra A, Burtness BA, Husain ZA.

Sci Rep. 2018 Sep 19;8(1):14036. doi: 10.1038/s41598-018-32441-y.

11.

Prophylactic Cranial Irradiation Versus Surveillance: Physician Bias and Patient-centered Decision-making.

Johnson SB, Decker RH.

Clin Lung Cancer. 2018 Nov;19(6):464-466. doi: 10.1016/j.cllc.2018.08.003. Epub 2018 Aug 22.

PMID:
30201223
12.

High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.

Kelada OJ, Decker RH, Nath SK, Johung KL, Zheng MQ, Huang Y, Gallezot JD, Liu C, Carson RE, Oelfke U, Carlson DJ.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):174-183. doi: 10.1016/j.ijrobp.2018.05.032. Epub 2018 Jun 1.

13.

Harnessing the Immunomodulatory Effects of Radiation Therapy.

Campbell AM, Decker RH.

Oncology (Williston Park). 2018 Jul 15;32(7):370-4, CV3. Review.

14.

Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.

Siegel J, Totonchy M, Damsky W, Berk-Krauss J, Castiglione F Jr, Sznol M, Petrylak DP, Fischbach N, Goldberg SB, Decker RH, Stamatouli AM, Hafez N, Glusac EJ, Tomayko MM, Leventhal JS.

J Am Acad Dermatol. 2018 Dec;79(6):1081-1088. doi: 10.1016/j.jaad.2018.07.008. Epub 2018 Jul 17.

PMID:
30025829
15.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.

Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA.

Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16.

16.

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.

Shukla ND, Salahudeen AA, Taylor GA, Ramalingam SS, Vokes EE, Goss GD, Decker RH, Kelly K, Scagliotti GV, Mok TS, Wakelee HA.

Clin Lung Cancer. 2018 Sep;19(5):377-386. doi: 10.1016/j.cllc.2018.03.004. Epub 2018 Mar 17. Review.

17.

Postoperative Chemoradiation in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Bhatia AK, Burtness BA, Decker RH.

J Clin Oncol. 2018 May 1;36(13):1269-1271. doi: 10.1200/JCO.2018.77.7987. Epub 2018 Mar 16. No abstract available.

PMID:
29547345
18.

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.

Goldberg SB, Narayan A, Kole AJ, Decker RH, Teysir J, Carriero NJ, Lee A, Nemati R, Nath SK, Mane SM, Deng Y, Sukumar N, Zelterman D, Boffa DJ, Politi K, Gettinger SN, Wilson LD, Herbst RS, Patel AA.

Clin Cancer Res. 2018 Apr 15;24(8):1872-1880. doi: 10.1158/1078-0432.CCR-17-1341. Epub 2018 Jan 12.

19.

Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.

Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, Abrams RA, Shu HG, Curran WJ Jr, Crocker IR, Patel KR.

J Neurooncol. 2018 Jan;136(2):289-298. doi: 10.1007/s11060-017-2652-0. Epub 2017 Nov 9.

20.

Response.

Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA.

J Natl Cancer Inst. 2018 Apr 1;110(4):433-434. doi: 10.1093/jnci/djx230. No abstract available.

PMID:
29121329
21.

Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.

Gao SJ, Kim AW, Puchalski JT, Bramley K, Detterbeck FC, Boffa DJ, Decker RH.

Lung Cancer. 2017 Jul;109:36-41. doi: 10.1016/j.lungcan.2017.04.018. Epub 2017 Apr 25.

PMID:
28577947
22.

Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer.

Campbell AM, Decker RH.

Transl Lung Cancer Res. 2017 Apr;6(2):220-229. doi: 10.21037/tlcr.2017.03.02. Review.

23.

Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.

Bledsoe TJ, Park HS, Stahl JM, Yarbrough WG, Burtness BA, Decker RH, Husain ZA.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx042.

PMID:
28521361
24.

Radiation Pneumonitis.

Bledsoe TJ, Nath SK, Decker RH.

Clin Chest Med. 2017 Jun;38(2):201-208. doi: 10.1016/j.ccm.2016.12.004. Epub 2017 Mar 1. Review.

PMID:
28477633
25.

Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.

Kelada OJ, Rockwell S, Zheng MQ, Huang Y, Liu Y, Booth CJ, Decker RH, Oelfke U, Carson RE, Carlson DJ.

Mol Imaging Biol. 2017 Dec;19(6):893-902. doi: 10.1007/s11307-017-1083-9.

26.

The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.

An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA.

Cancer. 2017 Jul 15;123(14):2762-2772. doi: 10.1002/cncr.30598. Epub 2017 Mar 21.

27.

Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.

Verma V, Shostrom VK, Zhen W, Zhang M, Braunstein SE, Holland J, Hallemeier CL, Harkenrider MM, Iskhanian A, Jabbour SK, Attia A, Lee P, Wang K, Decker RH, McGarry RC, Simone CB 2nd.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):778-785. doi: 10.1016/j.ijrobp.2016.11.049. Epub 2016 Dec 2.

PMID:
28244414
28.

Trends in stereotactic body radiation therapy for stage I small cell lung cancer.

Stahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB 2nd, Kim AW, Decker RH.

Lung Cancer. 2017 Jan;103:11-16. doi: 10.1016/j.lungcan.2016.11.009. Epub 2016 Nov 16.

PMID:
28024690
29.

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.

Verma V, Simone CB 2nd, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, Attia A, Zeng J, Biswas T, Paximadis P, Wang F, Walker JM, Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2.

PMID:
28011047
30.

Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall.

Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW.

Clin Lung Cancer. 2017 Mar;18(2):169-177.e4. doi: 10.1016/j.cllc.2016.08.005. Epub 2016 Oct 17.

PMID:
27890561
31.

The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1011-1020. doi: 10.1016/j.ijrobp.2016.08.033. Epub 2016 Aug 31.

PMID:
27869080
32.

Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.

Verma V, Shostrom VK, Kumar SS, Zhen W, Hallemeier CL, Braunstein SE, Holland J, Harkenrider MM, S Iskhanian A, Neboori HJ, Jabbour SK, Attia A, Lee P, Alite F, Walker JM, Stahl JM, Wang K, Bingham BS, Hadzitheodorou C, Decker RH, McGarry RC, Simone CB 2nd.

Cancer. 2017 Feb 15;123(4):688-696. doi: 10.1002/cncr.30375. Epub 2016 Oct 14.

33.

A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA.

JAMA Oncol. 2017 Mar 1;3(3):358-365. doi: 10.1001/jamaoncol.2016.4581.

PMID:
27737449
34.

Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.

Gao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW.

J Thorac Oncol. 2017 Feb;12(2):314-322. doi: 10.1016/j.jtho.2016.09.122. Epub 2016 Oct 5.

35.

Disparities in radiation therapy delivery: current evidence and future directions in head and neck cancer.

Park HS, Decker RH.

Cancers Head Neck. 2016 Jun 13;1:5. doi: 10.1186/s41199-016-0005-x. eCollection 2016. Review.

36.

Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.

Mancini BR, Park HS, Harder EM, Rutter CE, Corso CD, Decker RH, Husain ZA.

Lung Cancer. 2016 Jul;97:22-7. doi: 10.1016/j.lungcan.2016.04.011. Epub 2016 Apr 19.

PMID:
27237023
37.

Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.

Harder EM, Park HS, Chen ZJ, Decker RH.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e353-e359. doi: 10.1016/j.prro.2016.01.015. Epub 2016 Feb 4.

PMID:
27156424
38.

Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.

Lester-Coll NH, Park HS, Rutter CE, Corso CD, Young MR, Ratner ES, Litkouhi B, Decker RH, Yu JB, Damast S.

Gynecol Oncol. 2016 Jul;142(1):54-61. doi: 10.1016/j.ygyno.2016.04.544. Epub 2016 May 13.

PMID:
27151429
39.

Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.

Rosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW, Detterbeck FC, Boffa DJ.

J Thorac Cardiovasc Surg. 2016 Jul;152(1):44-54.e9. doi: 10.1016/j.jtcvs.2016.03.060. Epub 2016 Apr 7.

40.

Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases.

Lester-Coll NH, Rutter CE, Bledsoe TJ, Goldberg SB, Decker RH, Yu JB.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):663-72. doi: 10.1016/j.ijrobp.2016.01.020. Epub 2016 Jan 19.

PMID:
27055395
41.

Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Husain ZA, Burtness BA, Decker RH.

J Clin Oncol. 2016 Feb 10;34(5):396-8. doi: 10.1200/JCO.2015.64.7586. Epub 2015 Dec 7. No abstract available.

PMID:
26644528
42.

Taking "the Game" Out of The Match: A Simple Proposal.

Wu AJ, Vapiwala N, Chmura SJ, Das P, Decker RH, Terezakis SA, Zietman AL.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):945-8. doi: 10.1016/j.ijrobp.2015.09.039. Epub 2015 Nov 11. No abstract available.

PMID:
26581129
43.

Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.

Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB.

Am J Clin Oncol. 2018 Feb;41(2):152-158. doi: 10.1097/COC.0000000000000245.

PMID:
26523443
44.

Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.

Corso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, Husain ZA, Lilenbaum RC, Yu JB, Decker RH.

J Clin Oncol. 2015 Dec 20;33(36):4240-6. doi: 10.1200/JCO.2015.62.4270. Epub 2015 Oct 19.

45.

Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.

Harder EM, Park HS, Nath SK, Mancini BR, Decker RH.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e643-9. doi: 10.1016/j.prro.2015.07.003. Epub 2015 Jul 17.

PMID:
26412341
46.

Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.

Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH.

Lung Cancer. 2015 Nov;90(2):243-8. doi: 10.1016/j.lungcan.2015.08.002. Epub 2015 Aug 8.

PMID:
26277031
47.

Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.

Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB.

J Clin Oncol. 2015 Sep 1;33(25):2727-34. doi: 10.1200/JCO.2015.61.1517. Epub 2015 Jun 22.

PMID:
26101240
48.

Racial disparities in the use of SBRT for treating early-stage lung cancer.

Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH.

Lung Cancer. 2015 Aug;89(2):133-8. doi: 10.1016/j.lungcan.2015.05.002. Epub 2015 May 12.

PMID:
26051446
49.

The cost of cancer-related physician services to Medicare.

Maroongroge S, Kim SP, Mougalian S, Johung K, Decker RH, Soulos PR, Long JB, Gross CP, Yu JB.

Yale J Biol Med. 2015 Jun 1;88(2):107-14. eCollection 2015 Jun.

50.

Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.

Harder EM, Chen ZJ, Park HS, Mancini BR, Decker RH.

Am J Clin Oncol. 2017 Oct;40(5):477-482. doi: 10.1097/COC.0000000000000195.

PMID:
26017483

Supplemental Content

Loading ...
Support Center